Clinical Trial Update: The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux [Phase 4]

View source ↗

Summary

The Phase 4 study investigating Eustachian Tube Dysfunction and Laryngopharyngeal Reflux (NCT02123498) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eustachian Tube Dysfunction
• Laryngopharyngeal Reflux

Snippet

Sponsor: Loma Linda University | Conditions: Eustachian Tube Dysfunction, Laryngopharyngeal Reflux | Phase 4 | Status: WITHDRAWN